Apply to trial NCT07850284

A few quick questions so the study team can decide if you might be a fit.

RecruitingClinical trial

SMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders

This study evaluates whether daily SMS-based (text messages) symptom monitoring is feasible and acceptable in patients who are undergoing treatment for multiple myeloma (MM) or systemic light chain amyloidosis (AL), and whether it can help in early identification of symptoms that may require clinical attention.

How this works

Answer a few questions
About 5 to 10 minutes. Skip-friendly where possible.
We connect you with the study team
When a site picks up your application, we introduce you to their team directly — with you on the thread.
The team reaches out to schedule screening
Usually within a few business days, via the contact you give.

EmailWe save your progress under this email and copy you when we connect you with the study team.

I agree that Hipa.ai may share my application — my name, contact details, and my answers, including health information — with the official study team for this trial so they can review my responses and contact me.

By continuing, you agree to our terms of service.

SMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders

How this works

Answer a few questions

We connect you with the study team

The team reaches out to schedule screening